Top

Published in:

Open Access 01-05-2020 | Radiotherapy | Consensus Statement

Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery

Authors: Matthias Guckenberger, MD, Wolfgang W. Baus, PhD, Oliver Blanck, PhD, Stephanie E. Combs, MD, Jürgen Debus, MD, PhD, Rita Engenhart-Cabillic, MD, Tobias Gauer, PhD, Anca L. Grosu, MD, Daniela Schmitt, PhD, Stephanie Tanadini-Lang, PhD, Christos Moustakis, PhD

Published in: Strahlentherapie und Onkologie | Issue 5/2020

Abstract

Stereotactic radiotherapy with its forms of intracranial stereotactic radiosurgery (SRS), intracranial fractionated stereotactic radiotherapy (FSRT) and stereotactic body radiotherapy (SBRT) is today a guideline-recommended treatment for malignant or benign tumors as well as neurological or vascular functional disorders. The working groups for radiosurgery and stereotactic radiotherapy of the German Society for Radiation Oncology (DEGRO) and for physics and technology in stereotactic radiotherapy of the German Society for Medical Physics (DGMP) have established a consensus statement about the definition and minimal quality requirements for stereotactic radiotherapy to achieve best clinical outcome and treatment quality in the implementation into routine clinical practice.

Guckenberger M, Andratschke N, Alheit H et al (2014) Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer. Strahlenther Onkol 190(1):26–33CrossRef

Kocher M, Wittig A, Piroth MD et al (2014) Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol 190(6):521–532CrossRef

Sterzing F, Brunner TB, Ernst I et al (2014) Stereotactic body radiotherapy for liver tumors: principles and practical guidelines of the DEGRO working group on Stereotactic radiotherapy. Strahlenther Onkol 190(10):872–881CrossRef

Panje C, Andratschke N, Brunner TB et al (2016) Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer: literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol 192(12):875–885CrossRef

Guckenberger M, Andratschke N, Dieckmann K et al (2017) ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer. Radiother Oncol 124(1):11–17CrossRef

American College of Radiology (2016) ACR-ASTRO practice parameter for the performance of brain stereotactic radiosurgery. https://www.acr.org/-/media/ACR/Files/Practice-Parameters/stereobrain.pdf. Accessed 22 Mar 2019

American College of Radiology (2014) ACR-ASTRO practice parameter for the performance of stereotactic body radiation therapy. https://www.acr.org/-/media/ACR/Files/Practice-Parameters/SBRT-RO.pdf. Accessed 22 Mar 2019

SABR UK Consortium (2019) Stereotactic Ablative Body Radiation Therapy (SABR): A Resource. https://www.sabr.org.uk/wp-content/uploads/2019/04/SABRconsortium-guidelines-2019-v6.1.0.pdf. Accessed 22 Mar 2019

Schmitt D, Blanck O, Gauer T et al (2020) Technological quality requirements for stereotactic radiotherapy Expert review group consensus from the DGMP working group for physics and technology in stereotactic radiotherapy. Strahlenther Onkol. https://doi.org/10.1007/s00066-020-01583-2 CrossRefPubMed

10.

Wilke L, Andratschke N, Blanck O et al (2019) ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams: Statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery. Strahlenther Onkol 195(3):193–198CrossRef

Title: Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery
Authors: Matthias Guckenberger, MD
Wolfgang W. Baus, PhD
Oliver Blanck, PhD
Stephanie E. Combs, MD
Jürgen Debus, MD, PhD
Rita Engenhart-Cabillic, MD
Tobias Gauer, PhD
Anca L. Grosu, MD
Daniela Schmitt, PhD
Stephanie Tanadini-Lang, PhD
Christos Moustakis, PhD
Publication date: 01-05-2020
Publisher: Springer Berlin Heidelberg
Keyword: Radiotherapy
Published in: Strahlentherapie und Onkologie / Issue 5/2020
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-020-01603-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2020

Magnetic resonance imaging for brain stereotactic radiotherapy

Correction to: Long-term endothelial dysfunction in irradiated vessels: an immunohistochemical analysis

Re-irradiation for recurrent glioblastoma multiforme: a critical comparison of different concepts

Technological quality requirements for stereotactic radiotherapy

53BP1 expression and immunoscore are associated with the efficacy of neoadjuvant chemoradiotherapy for rectal cancer

Zusammenhang einer vorherigen antibiotischen Therapie mit dem Therapieansprechen auf Immuncheckpoint-Inhibitoren und dem Überleben bei Krebspatienten